IBIDS_Database

Intravenous sulprostone and uterine scarring based upon 22 cases of therapeutic abortion during 2nd and 3rd trimesters of pregnancy.
      

Record Detail

Return to previous page
Save:
Title: Intravenous sulprostone and uterine scarring based upon 22 cases of therapeutic abortion during 2nd and 3rd trimesters of pregnancy.
Author: Marpeau, L : Percque, M : Larue, L : Guettier, X : Jault, T : Pigne, A : Barrat, J
Citation: Eur-J-Obstet-Gynecol-Reprod-Biol. 1993 Jul; 50(2): 105-8
Abstract: A preliminary study in 22 patients with uterine scarring was undertaken using sulprostone by intravenous infusion when therapeutic abortion was deemed necessary during the 2nd and 3rd trimesters of pregnancy. The dosage used was 500 micrograms by slow infusion lasting 10 h. There were no cases of ruptured uterus. Adverse reactions were absent. Results were satisfactory. Mean induction-expulsion duration: 11 h. Expulsion rate in 24 h: 63%. With strict monitoring and in a specialized center, this technique may be suggested when a late therapeutic abortion with a scarred uterus is indicated.
Review References: None
Notes: None
Language: English
Publication Type: Journal-Article
Keywords: Abortifacient Agents, Nonsteroidal administration and dosage : Abortion, Therapeutic : Cicatrix complications : Dinoprostone analogs and derivatives : Uterine Diseases complications
URL: http://www.elsevier.nl/inca/publications/store/5/0/5/9/6/1/index.htt